E. coli-derived recombinant human FGF-19, Phe27-Lys216, Accession # O95750
Specificity
Detects human FGF-19 in direct ELISAs and Western blots. Shows approximately 10% cross-reactivity with recombinant human (rh) FGF-3 and rhFGF-5 and no cross-reactivity with rhFGF-4, rhFGF-6, rhFGF-7, rhFGF-9, rhFGF-10, rhFGF-13, rhFGF-16, rhFGF-17, rhFGF-18, rhFGF acidic, and rhFGF basic.
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. Small pack size is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Application
Western Blot; Blockade of Receptor-ligand Interaction; ELISA
Full Name
Fibroblast Growth Factor 19
Alternative Names
FGF19; FGF-19; fibroblast growth factor 19
Entrez Gene IDs/Gene IDs
9965 (Human)
Endotoxin
<0.10 EU/μg by the LAL method.
Storage
At -20°C for one year. After reconstitution , at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.6 months, -20 to -70 °C under sterile conditions after reconstitution.
For research or further manufacturing use only. Not for use in humans.
CONTACT US
USA
Europe
ABOUT US
As a pioneer of biotechnology, Creative Bioarray has developed into a leading biotechnology company in the world. We are committed to providing our customers with innovative high-quality products and services through discovering, developing, and manufacturing.